A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
... analysis included descriptive statistics. Data processing was performed in Microsoft Excel 2022 MSO software (version 2312 Build 16.0.17126.20132). Results: The study found that the US and EU have introduced drug policies that encourage the development of orphan drugs, while the Republic of Kazakhstan has yet to develop a clear policy, which is a contributing factor to the lower number of approved drugs for rare diseases in the country. The domestic list of orphan drugs includes 14.8% of the total number ...
Изменен: 28.02.2024Путь: Главная / Home / Publications
Результаты поиска 1 1 из 1
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате